IRMD, worth watching/trading.
Pluses:
High sequential growth rate.
Positive net cash flow.
No debt.
Market cap of $263M = good buyout candidate.
Beats earnings regularly. Next due Feb 5.
Regularly trends higher after earnings release (unlike $SPX). Predictable trade candidate.
Has tracked $SPX downward since November. Chart_Pattern/SR trade.
Minuses:
Has tracked $SPX downward since November, but at higher rate of decline.
(But that could be an advantage while on the way back up. So wait for earnings release?)
IRMD has lower support if $SPX is inclined to go lower. And, again, it has gone down faster than $SPX.